Griknil PG 2mg/500mg/15mg Tablet SR
Marketer
Aplonis Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Griknil PG 2mg/500mg/15mg Tablet SR
Diabex Trio 2mg/500mg/15mg Extended-Release Tablets combine three medications to effectively manage blood glucose. This therapy, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and frequency for Diabex Trio. Administer this medication with food to minimize gastrointestinal discomfort. Should you miss a dose, take it immediately; however, if your next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or missed meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Your physician will assess your kidney function prior to initiating this therapy. Limit alcohol consumption as it may potentiate side effects.
Uses of Griknil PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Griknil PG 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Griknil PG 2mg/500mg/15mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.
Common Side effects of Griknil PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Griknil PG 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume Griknil PG 2mg/500mg/15mg Extended-Release Tablets with a meal.
How Griknil PG 2mg/500mg/15mg Tablet SR works:
Griknil PG 2mg/500mg/15mg Extended-Release Tablets contain glimepiride, metformin, and pioglitazone—a triple-action antidiabetic regimen. These medications employ distinct methods to optimize blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Griknil PG 2mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Griknil PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Griknil PG tablets (2mg/500mg/15mg) are likely not safe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Griknil PG 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Griknil PG 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Patients with liver impairment should use Griknil PG 2mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Griknil PG 2mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Griknil PG 2mg/500mg/15mg Tablet SR :
Should you forget a Griknil PG 2mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Griknil PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Medication | Medication for diabetes |
3,018 People bought this recently